Wakefit Innovations Q4 FY26 Results: PAT Rs 122 Cr

Updated: 22 May 2026 • 2:06 pm

Posted by:

Wakefit Innovations Q4 FY26 Results: PAT Rs 122 Cr

Wakefit Innovations Q4 FY26 results were declared on May 21, 2026. The company reported PAT of Rs 122 crore for the quarter ended March 31, 2026, up 217.0% YoY compared to Rs 38.5 crore in Q4 FY25. Revenue from operations stood at Rs 620 crore, up 14.0% YoY. Results are on a Consolidated basis. Wakefit Innovations is a D2C Sleep and Home Products company listed on Indian stock exchanges.

Click Here – Get Free Investment Predictions

Table of Contents

Wakefit Innovations Q4 FY26 Financial Highlights

Metric	Q4 FY26 (Rs Cr)	Q4 FY25 (Rs Cr)	YoY Change
Revenue	Rs 620 crore	Rs 544 crore	+14.0%
Net Profit	122	38.5	+217.0%
Basis	Consolidated

Note: Q4 FY26 PAT skyrocketed to Rs 122 crore (+217% YoY) on revenue Rs 620 crore (+14% YoY). Strong D2C mattress and home products brand growth. Verify from BSE/NSE audited filings before investment decisions.

Wakefit Innovations Q4 FY26 Performance Analysis

The Wakefit Innovations Q4 FY26 results reflect the company’s operational performance during the January to March 2026 quarter. The quarter demonstrates strong earnings growth, reflecting improved operational execution and demand conditions. Wakefit Innovations operates in the D2C Sleep and Home Products sector, benefiting from India’s GDP growth above 6.5% in FY26 and sustained domestic demand conditions.

Revenue of Rs 620 crore was up 14.0% YoY. Steady revenue momentum reflects consistent business conditions.

Screen the best stocks on the Univest Screener.

Key Factors Driving Wakefit Innovations Q4 FY26 Results

Revenue and Operational Performance

Revenue of Rs 620 crore in Wakefit Innovations Q4 FY26 was up 14.0% YoY. Revenue performance reflects stable demand conditions. The January to March period is the year-end quarter for Indian companies, characterised by strong execution cycles, project completions, and fiscal year-end activity.

Profitability Trends

The Wakefit Innovations Q4 FY26 PAT of Rs 122 crore up 217.0% YoY. The PAT growth of 217% YoY demonstrates operational leverage and improving business fundamentals.

Sector and Macro Context

India’s macro environment in Q4 FY26 was supportive, with GDP growth above 6.5%, government capital expenditure of Rs 11.21 lakh crore budgeted for FY27, and resilient domestic consumption. The D2C Sleep and Home Products sector saw broadly constructive demand conditions. For Wakefit Innovations, these macro tailwinds provided a supportive backdrop entering FY27.

FY27 Outlook

Following Wakefit Innovations Q4 FY26 results, management commentary on FY27 revenue guidance, margin improvement trajectory, and capital allocation priorities will be the key investor watchpoints. The D2C Sleep and Home Products sector continues to benefit from India’s structural growth drivers. Sustaining the strong earnings momentum will be the primary FY27 focus.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.

Frequently Asked Questions on the firm

What is Wakefit Innovations Q4 FY26 net profit?

Ans. Wakefit Innovations Q4 FY26 PAT of Rs 122 crore, up 217.0% YoY from Rs 38.5 crore in Q4 FY25. Results declared May 21, 2026, on a Consolidated basis. Verify from BSE/NSE audited filings.

What is Wakefit Innovations Q4 FY26 revenue?

Ans. Wakefit Innovations Q4 FY26 revenue from operations was Rs 620 crore, up 14.0% YoY. Verify from BSE/NSE filings for complete audited breakdown.

When were Wakefit Innovations Q4 FY26 results declared?

Ans. Wakefit Innovations Q4 FY26 results were declared on May 21, 2026, at the board of directors meeting approving audited Q4 and FY26 financial statements.

Is Wakefit Innovations a good investment after Q4 FY26?

Ans. Investment decisions require individual assessment of fundamentals, valuation, and risk tolerance. This article is for educational purposes only. Consult a SEBI-registered financial advisor before investing in Wakefit Innovations.

Also Read

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Verify all figures from BSE/NSE filings. Consult a SEBI-registered financial advisor.